| Post | Subject | | |
#2395
0
|
Went over to the Yahoo board to see
|
antihama
| 12/13/18 12:18:06 PM |
|
#2394
0
|
Interesting how this downdraft in tech affects Spectrum Pharma.
|
antihama
| 12/08/18 08:06:16 AM |
|
#2393
0
|
err Wrapping :)
|
Doji Dragonfly
| 12/07/18 05:06:45 AM |
|
#2392
0
|
They are taking there sweet time warping our
|
Doji Dragonfly
| 12/07/18 05:05:42 AM |
|
#2391
0
|
Are they looking to hire more Clinical/Regulatory?
|
antihama
| 12/06/18 12:06:55 PM |
|
#2390
0
|
Ya know, from today's Rolontis RECOVER P3 PR,
|
antihama
| 12/06/18 11:03:53 AM |
|
#2389
0
|
Amgen’s receives FT based on 10 patients.
|
antihama
| 12/04/18 06:06:38 PM |
|
#2388
0
|
CASI Pharmaceuticals' EVOMELA approved in China!
|
antihama
| 12/03/18 02:00:00 PM |
|
#2387
0
|
Leucovorin Mitigates Mucositis in Patients Treated with FOLOTYN.
|
antihama
| 12/03/18 07:35:41 AM |
|
#2385
0
|
Sometimes, the words not spoken are the loudest.
|
antihama
| 11/23/18 08:08:21 AM |
|
#2384
0
|
CASI: H.C. Wainwright is maintaining its Buy rating
|
antihama
| 11/21/18 10:55:24 AM |
|
#2383
0
|
New Presentation; same as the Jefferies 2018 London
|
antihama
| 11/20/18 04:47:27 PM |
|
#2382
0
|
No problemo!
|
antihama
| 11/20/18 04:44:18 PM |
|
#2381
0
|
Pozi competition prognosis? Pozi is in good shape
|
antihama
| 11/20/18 04:43:07 PM |
|
#2380
0
|
Sorry antihama, he went on my least favorite
|
Doji Dragonfly
| 11/20/18 02:03:12 PM |
|
#2379
0
|
Hi Doji, can you do me a favor
|
antihama
| 11/19/18 11:26:45 PM |
|
#2378
0
|
Thanks for your input
|
Vavavoom
| 11/18/18 09:18:14 AM |
|
#2377
0
|
DS-8201a is not a competitor to Pozi exon20
|
antihama
| 11/18/18 07:22:36 AM |
|
#2376
0
|
I mean how did they identify the her2
|
Vavavoom
| 11/17/18 03:40:43 PM |
|
#2375
0
|
Antihama,
Any thoughts on ds-8201
|
Vavavoom
| 11/17/18 09:35:19 AM |
|
#2374
0
|
Comments on Jefferies London HCC CC 11.14.19
|
antihama
| 11/15/18 01:15:36 PM |
|
#2373
0
|
I don't think PFS will weigh-in on BTD
|
antihama
| 11/13/18 01:54:28 PM |
|
#2372
0
|
Ville is at 80%
|
Ville
| 11/13/18 11:41:27 AM |
|
#2371
0
|
A little doubt remains:
|
Ville
| 11/13/18 11:39:48 AM |
|
#2370
0
|
A Rolontis 'Guy', Dr. Vacirca joins the BOD.
|
antihama
| 11/13/18 07:58:39 AM |
|
#2369
0
|
make it 99% but not 100%
|
antihama
| 11/12/18 04:16:15 PM |
|
#2368
0
|
antihama....make it 99% but not 100% :)
|
Doji Dragonfly
| 11/12/18 03:54:50 PM |
|
#2367
0
|
Hi muchogusto,
|
antihama
| 11/12/18 02:39:13 PM |
|
#2366
0
|
Thank you antihama, for your insightful analysis.
|
muchogusto
| 11/11/18 03:42:07 AM |
|
#2365
0
|
3rd Q CC impressions.
|
antihama
| 11/09/18 08:41:28 AM |
|
#2364
0
|
Continuing evidence discrediting Sept's short article pozi pricing.
|
antihama
| 11/07/18 08:30:19 AM |
|
#2363
0
|
Janssen collaboration for NSCLC EGFR-TKI Valued up-to $1.25B
|
antihama
| 11/06/18 01:22:22 PM |
|
#2362
0
|
One small step for Evomela, one big step
|
antihama
| 11/06/18 08:14:32 AM |
|
#2361
0
|
PDX(Folotyn) has demonstrated compelling activity in combination with
|
antihama
| 11/05/18 04:57:59 PM |
|
#2360
0
|
Use of Leucovorin As Adjunct to Pralatrexate @ASH2018.
|
antihama
| 11/05/18 04:49:13 PM |
|
#2359
0
|
A long-time long's lament (or jealous of SGEN).
|
antihama
| 11/05/18 11:09:23 AM |
|
#2358
0
|
I’m saddened to think what this patient went
|
antihama
| 11/05/18 07:56:06 AM |
|
#2357
0
|
Metastatic Breast Cancer Patient With Activating HER2 Exon
|
AVII77
| 11/05/18 06:49:44 AM |
|
#2356
0
|
Combination with Kadcyla will be telling. I hope
|
Ville
| 11/05/18 05:56:24 AM |
|
#2355
0
|
Frankly i don't know. But it is not
|
Ville
| 11/05/18 05:54:24 AM |
|
#2354
0
|
Poziotinib showed the most potent activity against HER2
|
antihama
| 11/04/18 12:17:37 PM |
|
#2353
0
|
Reason #3 to why trial sites were removed.
|
antihama
| 11/03/18 10:11:54 AM |
|
#2352
0
|
Pozi P2 HER2 positive metastatic breast cancer study.
|
antihama
| 11/02/18 10:40:21 PM |
|
#2351
0
|
Oh Rolontis BLA where art thou?
|
antihama
| 11/01/18 02:38:21 PM |
|
#2350
0
|
Hi Ville,
|
kojak007
| 11/01/18 12:52:32 PM |
|
#2349
0
|
Pozi's future pan EGFR 'to do' list.
|
antihama
| 10/31/18 10:49:04 AM |
|
#2348
0
|
SPPI Pozi trial interim analysis early data readout.
|
antihama
| 10/30/18 10:19:15 AM |
|
#2347
0
|
So does Pozi fit the following criteria (rhetorical?)
|
antihama
| 10/29/18 05:18:52 PM |
|
#2346
0
|
That is an excellent overview antihama Thanks
|
Doji Dragonfly
| 10/29/18 03:11:04 PM |
|
#2345
0
|
FDA Expedited Programs Overview with Focus on BTD.
|
antihama
| 10/29/18 01:54:02 PM |
| Post | Subject | | |